Clinical trialPhase 4Completed
Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
Effects of Preoperative Immunonutrition on Infectious Complication and Th1/Th2 Differentiation in Patients Undergoing Pancreaticoduodenectomy
- Outcome
- Outcome unknown
- Phase
- Phase 4
- Status
- Completed
- Study type
- Interventional
- Start
- May 2009
- Expected end
- March 2012
- Enrollment
- 50 participants
- Sites
- 1
- Primary outcomes
- Postoperative Infectious Complication
- Sponsor
- Other
- Results posted
- 2012-10-23
- Last update
- 23 October 2012
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with pancreaticoduodenectomy.
Detailed description public domain (ClinicalTrials.gov)
The investigators reported that preoperative immunonutrition improve the incidence of postoperative infectious complication in patients after pancreaticoduodenectomy, and modulation of Th1/Th2 differentiation may play important roles in this effect. Object of this study is to investigate the effects preoperative immunonutrition on incidence of postoperative infectious complication, and Th1/Th2 balance after pancreaticoduodenectomy.
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
Postoperative Infectious Complication [30 days]. Number, participants. Group A (n=25): 7; Group B (n=25): 15. Analysis, Group A vs Group B: p=<0.05; Chi-squared; superiority or other.